Authors' reply

The Lancet

Volumn 382, Issue 9892, 2013, Pages 594-596

  Peto, Richard ^a   Awasthi, Shally ^b   Read, Simon ^a   Clark, Sarah ^a   Bundy, Donald ^c  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b KING GEORGE'S MEDICAL UNIVERSITY   (India)

^c WORLD BANK   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

RETINOL; DRUG DERIVATIVE; IMMUNOLOGICAL ADJUVANT;

CHILDHOOD MORTALITY; CLINICAL ASSESSMENT; HUMAN; LETTER; LOWEST INCOME GROUP; MEDICATION COMPLIANCE; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK REDUCTION; TREATMENT OUTCOME; VITAMIN BLOOD LEVEL; VITAMIN SUPPLEMENTATION; XEROPHTHALMIA; DIET SUPPLEMENTATION; FEMALE; MALE; NOTE; RETINOL DEFICIENCY;

ADJUVANTS, IMMUNOLOGIC; DIETARY SUPPLEMENTS; FEMALE; HUMANS; MALE; VITAMIN A; VITAMIN A DEFICIENCY;

EID: 84882260841     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(13)61463-4     Document Type: Letter

References (5)

1. Awasthi S, Peto R, Read S, Clark S, Pande V, Bundy D, and the DEVTA (Deworming and Enhanced Vitamin A) team. Vitamin A supplementation every 6 months with retinol in 1 million pre-school children in north India: DEVTA, a cluster-randomised trial. Lancet 2013; 381: 1469-77.
2. Garner P, Taylor-Robinson D, Sachdev HS. DEVTA: results from the biggest clinical trial ever. Lancet 2013; 381: 1439-41.
3. Peto R. Interpreting large-scale randomised evidence. John Snow lecture, April 12, 2013. http://www.youtube.com/watch?v=vybc0PsZ7 18&list= PL3oyPcbygtxuqmYps-aEj9Sa- ScThzMLh (accessed June 21, 2013).
4. EBCTCG. Treatment of early breast cancer: worldwide evidence, 1985-1990. Oxford: Oxford University Press, 1990. http://www.ctsu.ox.ac.uk/research/meta- trials/ebctcg/original-methods-for-ebctcg-meta-analyses (accessed June 21, 2013).
5. Sommer A, West KP, Martorell R. Vitamin A supplementation in Indian children. Lancet 2013; 382: 591